Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line treatment of hormone receptor-positive metastatic breast cancer in Greece: An evaluation study Annals of Oncology 25 2014 and BMC Health Serv Res. 2015 Aug
A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines J Cancer Res Cin Oncol. 2010 Jan
Safety and efficacy of trastuzumab every 3 weeks combined with cytotoxic chemotherapy in patients with HER-2 positive recurrent breast cancer: findings from a case series Oncologie. 2005 Nov
In vivo synergism between docetaxel and gemcitabine in patients with metastatic breast cancer: general concepts and future perspectives Semin Oncol. 2004 Apr
Phase II sudy of pegylated liposomal doxorubicin (Caelyx) and docetaxel as first-line treatment in metastatic breast cancer Ann Oncol. 2004 Jun
Evidence for in vivo synergism between docetaxel and gemcitabine in patients with metastatic breast cancer Ann Oncol. 2004 Jan
Gemcitabine plus irinotecan in breast cancer patients pretreated with taxanes and anthracyclines: a multicenter phase II study Oncology. 2003
Salvage treatment of metastatic breast cancer with docetaxel and carboplatin. A multicenter phase II trial Oncology. 2003
Docetaxel in combination with mitixantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: a multicenter phase II study Ann Oncol. 2001 Jun
Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomized multicenter trial Lancet. 2001 May